|
Market Closed -
Nasdaq
16:00:00 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1.440 USD | +11.63% |
|
+25.22% | -67.99% |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 8.59M | - | - | - | - | - |
| 73.96B | |||||
| 64.66B | |||||
| 27.32B | - | ||||
| 27.86B | - | ||||
| 25.97B |
- Stock Market
- Stocks
- FBLG Stock
- Charts FibroBiologics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
